Medicine
Ruconest 2100 units powder for injection
Ruconest 2100 units powder for injection is a prescription medicine containing Conestat alfa for intravenous use, marketed by Pharming Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in the original package in order to protect from light. Any product that…
Key facts
- Active ingredient (INN)
- Conestat alfa
- Brand
- Ruconest
- Strength
- 2100 units
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Pharming Healthcare
- Manufacturer
- Pharming Healthcare
- Origin register
- US FDA, United States
- Storage
- Store in the original package in order to protect from light. Any product that has been reconstituted should be used immediately, or within 8 hours stored at 36ºF - 46ºF (2ºC - 8ºC).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B06AC04 Conestat alfa
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2018
- Identifiers
- RxCUI 1599836, 1599841DailyMed set ID 66d3fecb-32a4-7781-e053-2a91aa0a83caNDC 71274-350Application BLA125495
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 1 injection, powder, for solution in 1 vial, single-use | 71274-350-02 | Pharming Healthcare | 1 April 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Conestat alfa is a prescription medicine indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE). It is available as powder for injection for intravenous use. MedsAcross supplies Conestat alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Conestat alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ruconest prescribing information (Pharming Healthcare) · U.S. National Library of Medicine, DailyMed
- Ruconest: European public assessment report (EPAR) · European Medicines Agency
Need Ruconest 2100 units powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.